Mirle Schemionek
- Hematology top 1%
- Molecular Biology
- Genetics top 2%
- Rheumatology top 5%
- Oncology
- Co-authors
- Steffen KoschmiederCarsten Müller‐TidowTessa L. HolyoakeAshley HamiltonRavi BhatiaTim H. BrümmendorfBernd H. A. RehmG. Vignir Helgason
- Topics
- Chronic Myeloid Leukemia Treatments (26 papers)Chronic Lymphocytic Leukemia Research (15 papers)Acute Myeloid Leukemia Research (12 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Mirle Schemionek
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Hematology 693
- Molecular Biology 512
- Genetics 434
- Rheumatology 213
- Oncology 171
Countries citing papers authored by Mirle Schemionek
This map shows the geographic impact of Mirle Schemionek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirle Schemionek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirle Schemionek more than expected).
Fields of papers citing papers by Mirle Schemionek
This network shows the impact of papers produced by Mirle Schemionek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirle Schemionek. The network helps show where Mirle Schemionek may publish in the future.
Co-authorship network of co-authors of Mirle Schemionek
This figure shows the co-authorship network connecting the top 25 collaborators of Mirle Schemionek. A scholar is included among the top collaborators of Mirle Schemionek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirle Schemionek. Mirle Schemionek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 19 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | 3 | |
| 9 | 38 | |
| 10 | 17 | |
| 11 | 62 | |
| 12 | 13 | |
| 13 | 32 | |
| 14 | 24 | |
| 15 | 42 | |
| 16 | 1 | |
| 17 | 48 | |
| 18 | 22 | |
| 19 | Is Bcr-Abl expression relevant for the survival of cancer stem cells in chronic myeloid leukaemia (CML)? | 1 |
| 20 | 0 |
About Mirle Schemionek
Mirle Schemionek is a scholar working on Hematology, Genetics and Rheumatology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (26 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Acute Myeloid Leukemia Research (12 papers). The work is most often cited by research in Hematology (693 citations), Genetics (434 citations) and Rheumatology (213 citations). Mirle Schemionek has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Steffen Koschmieder, Carsten Müller‐Tidow, Tessa L. Holyoake, Ashley Hamilton, Ravi Bhatia, Tim H. Brümmendorf, Bernd H. A. Rehm, G. Vignir Helgason, Elaine Allan and Franck E. Nicolini. Their work appears in journals such as Blood, PLoS ONE and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.